2
|
Thorgeirsson TE, Gudbjartsson DF, Sulem P, Besenbacher S, Styrkarsdottir U, Thorleifsson G, Walters GB, Furberg H, Sullivan PF, Marchini J, McCarthy MI, Steinthorsdottir V, Thorsteinsdottir U, Stefansson K. A common biological basis of obesity and nicotine addiction. Transl Psychiatry 2013; 3:e308. [PMID: 24084939 PMCID: PMC3818010 DOI: 10.1038/tp.2013.81] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2013] [Accepted: 07/22/2013] [Indexed: 12/12/2022] Open
Abstract
Smoking influences body weight such that smokers weigh less than non-smokers and smoking cessation often leads to weight increase. The relationship between body weight and smoking is partly explained by the effect of nicotine on appetite and metabolism. However, the brain reward system is involved in the control of the intake of both food and tobacco. We evaluated the effect of single-nucleotide polymorphisms (SNPs) affecting body mass index (BMI) on smoking behavior, and tested the 32 SNPs identified in a meta-analysis for association with two smoking phenotypes, smoking initiation (SI) and the number of cigarettes smoked per day (CPD) in an Icelandic sample (N=34,216 smokers). Combined according to their effect on BMI, the SNPs correlate with both SI (r=0.019, P=0.00054) and CPD (r=0.032, P=8.0 × 10(-7)). These findings replicate in a second large data set (N=127,274, thereof 76,242 smokers) for both SI (P=1.2 × 10(-5)) and CPD (P=9.3 × 10(-5)). Notably, the variant most strongly associated with BMI (rs1558902-A in FTO) did not associate with smoking behavior. The association with smoking behavior is not due to the effect of the SNPs on BMI. Our results strongly point to a common biological basis of the regulation of our appetite for tobacco and food, and thus the vulnerability to nicotine addiction and obesity.
Collapse
Affiliation(s)
| | | | - P Sulem
- Decode genetics/AMGEN, Sturlugata 8, Reykjavik, Iceland
| | - S Besenbacher
- Decode genetics/AMGEN, Sturlugata 8, Reykjavik, Iceland
- Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark
| | | | | | - G B Walters
- Decode genetics/AMGEN, Sturlugata 8, Reykjavik, Iceland
| | - TAG Consortium9
- Decode genetics/AMGEN, Sturlugata 8, Reykjavik, Iceland
- Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark
- Department of Epidemiology, Memorial Sloan Kettering Cancer Center, NY, USA
- Departments of Genetics and Psychiatry, CB# 7264, 5097 Genomic Medicine, NC, USA
- Wellcome Trust Centre of Human Genetics, Oxford, UK
- Department of Statistics, University of Oxford, Oxford, UK
- Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Oxford-GSK Consortium9
- Decode genetics/AMGEN, Sturlugata 8, Reykjavik, Iceland
- Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark
- Department of Epidemiology, Memorial Sloan Kettering Cancer Center, NY, USA
- Departments of Genetics and Psychiatry, CB# 7264, 5097 Genomic Medicine, NC, USA
- Wellcome Trust Centre of Human Genetics, Oxford, UK
- Department of Statistics, University of Oxford, Oxford, UK
- Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - ENGAGE consortium9
- Decode genetics/AMGEN, Sturlugata 8, Reykjavik, Iceland
- Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark
- Department of Epidemiology, Memorial Sloan Kettering Cancer Center, NY, USA
- Departments of Genetics and Psychiatry, CB# 7264, 5097 Genomic Medicine, NC, USA
- Wellcome Trust Centre of Human Genetics, Oxford, UK
- Department of Statistics, University of Oxford, Oxford, UK
- Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - H Furberg
- Department of Epidemiology, Memorial Sloan Kettering Cancer Center, NY, USA
| | - P F Sullivan
- Departments of Genetics and Psychiatry, CB# 7264, 5097 Genomic Medicine, NC, USA
| | - J Marchini
- Wellcome Trust Centre of Human Genetics, Oxford, UK
- Department of Statistics, University of Oxford, Oxford, UK
| | - M I McCarthy
- Wellcome Trust Centre of Human Genetics, Oxford, UK
- Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
| | | | - U Thorsteinsdottir
- Decode genetics/AMGEN, Sturlugata 8, Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - K Stefansson
- Decode genetics/AMGEN, Sturlugata 8, Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| |
Collapse
|
4
|
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman MT, Dörk T, Nevanlinna H, Ness RB, Rafnar T, Hogdall C, Hogdall E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, van Altena AM, Aben KK, Massuger LF, Brooks-Wilson A, Kelemen LE, Le ND, Jakubowska A, Lubinski J, Medrek K, Stafford A, Easton DF, Tyrer J, Bolton KL, Harrington P, Eccles D, Chen A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch HA, McLaughlin J, Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC, Beesley J, Webb PM, Chen X, Ekici AB, Thiel FC, Beckmann MW, Yang H, Wentzensen N, Lissowska J, Fasching PA, Despierre E, Amant F, Vergote I, Doherty J, Hein R, Wang-Gohrke S, Lurie G, Carney ME, Thompson PJ, Runnebaum I, Hillemanns P, Dürst M, Antonenkova N, Bogdanova N, Leminen A, Butzow R, Heikkinen T, Stefansson K, Sulem P, Besenbacher S, Sellers TA, Gayther SA, Pharoah PD, Pharoah PDP. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010; 42:874-9. [PMID: 20852632 PMCID: PMC3020231 DOI: 10.1038/ng.668] [Citation(s) in RCA: 274] [Impact Index Per Article: 19.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2010] [Accepted: 07/27/2010] [Indexed: 02/02/2023]
Abstract
Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify common low-penetrance ovarian cancer susceptibility genes, we conducted a genome-wide association study of 507,094 SNPs in 1,768 individuals with ovarian cancer (cases) and 2,354 controls, with follow up of 21,955 SNPs in 4,162 cases and 4,810 controls, leading to the identification of a confirmed susceptibility locus at 9p22 (in BNC2). Here, we report on nine additional candidate loci (defined as having P ≤ 10⁻⁴) identified after stratifying cases by histology, which we genotyped in an additional 4,353 cases and 6,021 controls. We confirmed two new susceptibility loci with P ≤ 5 × 10⁻⁸ (8q24, P = 8.0 × 10⁻¹⁵ and 2q31, P = 3.8 × 10⁻¹⁴) and identified two additional loci that approached genome-wide significance (3q25, P = 7.1 × 10⁻⁸ and 17q21, P = 1.4 × 10⁻⁷). The associations of these loci with serous ovarian cancer were generally stronger than with other cancer subtypes. Analysis of HOXD1, MYC, TIPARP and SKAP1 at these loci and of BNC2 at 9p22 supports a functional role for these genes in ovarian cancer development.
Collapse
Affiliation(s)
- Ellen L. Goode
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
| | - Georgia Chenevix-Trench
- The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia
| | - Honglin Song
- Cancer Research United Kingdom Department of Oncology University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
| | - Susan J. Ramus
- Department of Gynaecological Oncology, University College London, EGA Institute for Women's Health, London, United Kingdom
| | - Maria Notaridou
- Department of Gynaecological Oncology, University College London, EGA Institute for Women's Health, London, United Kingdom
| | - Kate Lawrenson
- Department of Gynaecological Oncology, University College London, EGA Institute for Women's Health, London, United Kingdom
| | - Martin Widschwendter
- Department of Gynaecological Oncology, University College London, EGA Institute for Women's Health, London, United Kingdom
| | - Robert A. Vierkant
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
| | - Melissa C. Larson
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
| | - Susanne K. Kjaer
- The Juliane Marie Centre, Department of Gynecology and Obstetrics, Rigshospitalet, Copenhagen, Denmark and Department of Virus, Hormones and Cancer Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
| | - Michael J. Birrer
- Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Andrew Berchuck
- Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA
| | - Joellen Schildkraut
- Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA
| | - Ian Tomlinson
- Centre for Molecular Oncology & Imaging, Institute of Cancer, Barts and The London School of Medicine and Dentistry, London, United Kingdom
| | - Lambertus A. Kiemeney
- Department of Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
| | - Linda S. Cook
- Division of Epidemiology and Biostatistics, University of New Mexico, Albuquerque, New Mexico and Alberta Health Services-Cancer Care, Calgary, AB, Canada
| | - Jacek Gronwald
- International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, ul. Polabska 4, 70-115 Szczecin, Poland
| | - Montserrat Garcia-Closas
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
| | - Martin E. Gore
- The Royal Marsden Hospital, Gynecological Oncology Unit, Fulham Road, London SW3 6JJ, United Kingdom
| | - Ian Campbell
- Centre for Cancer Genomics and Predictive Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia and Department of Pathology, University of Melbourne, Parkville, Victoria, Australia
| | - Alice S. Whittemore
- Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA
| | - Rebecca Sutphen
- University of South Florida, Pediatrics Epidemiology Center, College of Medicine, Tampa, Florida, USA
| | - Catherine Phelan
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
| | - Hoda Anton-Culver
- Department of Epidemiology, School of Medicine, University of California, Irvine, California
| | - Celeste Leigh Pearce
- University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, California, USA
| | | | - Mary Anne Rossing
- Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
| | - Jenny Chang-Claude
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany
| | - Kirsten B. Moysich
- Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York, USA
| | - Marc T. Goodman
- University of Hawaii, Cancer Research Center, Honolulu, Hawaii, USA
| | - Thilo Dörk
- Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany
| | - Heli Nevanlinna
- Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland
| | - Roberta B. Ness
- University of Texas School of Public Health, Houston, Texas, USA
| | | | - Claus Hogdall
- The Juliane Marie Centre, Department of Gynecology and Obstetrics, Rigshospitalet, Copenhagen, Denmark
| | - Estrid Hogdall
- Department of Virus, Hormones and Cancer Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
| | - Brooke L. Fridley
- Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
| | - Julie M. Cunningham
- Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
| | - Weiva Sieh
- University of South Florida, Pediatrics Epidemiology Center, College of Medicine, Tampa, Florida, USA
| | - Valerie McGuire
- University of South Florida, Pediatrics Epidemiology Center, College of Medicine, Tampa, Florida, USA
| | - Andrew K. Godwin
- Women's Cancer Program, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
| | - Daniel W. Cramer
- Obstetrics and Gynecology Epidemology Center, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Dena Hernandez
- National Institutes of Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Douglas Levine
- Memorial Sloan-Kettering Cancer Center, New York, New York, USA
| | - Karen Lu
- MD Anderson Cancer Center, Houston, Texas, USA
| | - Edwin S. Iversen
- Department of Statistics, Duke University, Durham, North Carolina, USA
| | - Rachel T. Palmieri
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Richard Houlston
- Molecular and Population Genetics Team, The Institute of Cancer Research: Royal Cancer Hospital, London, United Kingdom
| | - Anne M. van Altena
- Department of Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
| | | | - Leon F.A.G. Massuger
- Department of Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
| | - Angela Brooks-Wilson
- Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada and Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada
| | | | - Nhu D. Le
- Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada
| | - Anna Jakubowska
- International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, ul. Polabska 4, 70-115 Szczecin, Poland
| | - Jan Lubinski
- International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, ul. Polabska 4, 70-115 Szczecin, Poland
| | - Krzysztof Medrek
- International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, ul. Polabska 4, 70-115 Szczecin, Poland
| | - Anne Stafford
- Cancer Research United Kingdom Department of Oncology University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
| | - Douglas F. Easton
- Cancer Research United Kingdom Genetic Epidemiology Unit, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
| | - Jonathan Tyrer
- Cancer Research United Kingdom Department of Oncology University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
| | - Kelly L. Bolton
- Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, United Kingdom
| | - Patricia Harrington
- Cancer Research United Kingdom Department of Oncology University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
| | - Diana Eccles
- University of Southampton School of Medicine, WCGS Princess Anne Hospital, Southampton SO16 5YA, UK
| | - Ann Chen
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
| | - Ashley N. Molina
- Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA
| | - Barbara N. Davila
- Division of Epidemiology and Biostatistics, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California, USA
| | - Hector Arango
- West Coast Gynecologic Oncology, Clearwater, Florida, USA
| | - Ya-Yu Tsai
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
| | - Zhihua Chen
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
| | - Harvey A. Risch
- Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticutt, USA
| | | | - Steven A. Narod
- Women's College Research Institute, University of Toronto, Canada
| | - Argyrios Ziogas
- Department of Epidemiology, School of Medicine, University of California, Irvine, California
| | - Wendy Brewster
- Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
| | - Aleksandra Gentry-Maharaj
- Department of Gynaecological Oncology, University College London, EGA Institute for Women's Health, London, United Kingdom
| | - Usha Menon
- Department of Gynaecological Oncology, University College London, EGA Institute for Women's Health, London, United Kingdom
| | - Anna H. Wu
- University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, California, USA
| | - Daniel O. Stram
- University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, California, USA
| | - Malcolm C. Pike
- University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, California, USA
| | | | - Jonathan Beesley
- The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia
| | - Penelope M. Webb
- The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia
| | | | | | - Xiaoqing Chen
- The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Australia
| | - Arif B. Ekici
- Institute of Human Genetics, Friedrich Alexander University Erlangen Nuremberg, Erlangen, Germany
| | - Falk C. Thiel
- University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany
| | - Matthias W. Beckmann
- Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, WH Roentgena 5, 00-782 Warsaw, Poland
| | - Hannah Yang
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
| | - Nicolas Wentzensen
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA
| | - Jolanta Lissowska
- Department of Cancer Epidemiology and Prevention, The M. Sklodowska-Curie Cancer Center and Institute of Oncology, WH Roentgena 5, 00-782 Warsaw, Poland
| | - Peter A. Fasching
- Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA
| | - Evelyn Despierre
- Department of Gynaecologic Oncology, University Hospitals Leuven, Belgium
| | - Frederic Amant
- Department of Gynaecologic Oncology, University Hospitals Leuven, Belgium
| | - Ignace Vergote
- Department of Gynaecologic Oncology, University Hospitals Leuven, Belgium
| | - Jennifer Doherty
- Program in Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
| | - Rebecca Hein
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany
| | - Shan Wang-Gohrke
- Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany
| | - Galina Lurie
- University of Hawaii, Cancer Research Center, Honolulu, Hawaii, USA
| | | | | | - Ingo Runnebaum
- The Juliane Marie Centre, Department of Gynecology and Obstetrics, Rigshospitalet, Copenhagen, Denmark and Department of Virus, Hormones and Cancer Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
| | - Peter Hillemanns
- Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany
| | - Matthias Dürst
- Clinics of Obstetrics and Gynaecology, Friedrich Schiller University, Jena, Germany
| | - Natalia Antonenkova
- Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus
| | - Natalia Bogdanova
- Byelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus and Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany
| | - Arto Leminen
- Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland
| | - Ralf Butzow
- Department of Obstetrics and Gynecology and Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland
| | - Tuomas Heikkinen
- Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland
| | | | - Patrick Sulem
- deCODE Genetics, Sturlugata 8, 101 Reykjavik, Iceland
| | | | - Thomas A. Sellers
- H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
| | - Simon A. Gayther
- Department of Gynaecological Oncology, University College London, EGA Institute for Women's Health, London, United Kingdom
| | - Paul D.P. Pharoah
- Cancer Research United Kingdom Department of Oncology and Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom
| | | | | |
Collapse
|